Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
12752 | 820 | 45.3 | 76% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
630 | 13104 | CYTOMEGALOVIRUS//HUMAN CYTOMEGALOVIRUS//HHV 6 |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | MURINE CYTOMEGALOVIRUS | Author keyword | 16 | 34% | 5% | 38 |
2 | MCMV | Author keyword | 13 | 42% | 3% | 25 |
3 | LY49H | Author keyword | 6 | 80% | 0% | 4 |
4 | MEMORY INFLATION | Author keyword | 4 | 67% | 0% | 4 |
5 | M157 | Author keyword | 3 | 100% | 0% | 3 |
6 | TSM5 | Author keyword | 3 | 100% | 0% | 3 |
7 | MOUSE CYTOMEGALOVIRUS | Author keyword | 3 | 45% | 1% | 5 |
8 | IMMUNOL VIROL PROGRAM | Address | 2 | 18% | 1% | 12 |
9 | ANTIVIRAL CONTROL | Author keyword | 2 | 67% | 0% | 2 |
10 | CTL LINE | Author keyword | 2 | 67% | 0% | 2 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | MURINE CYTOMEGALOVIRUS | 16 | 34% | 5% | 38 | Search MURINE+CYTOMEGALOVIRUS | Search MURINE+CYTOMEGALOVIRUS |
2 | MCMV | 13 | 42% | 3% | 25 | Search MCMV | Search MCMV |
3 | LY49H | 6 | 80% | 0% | 4 | Search LY49H | Search LY49H |
4 | MEMORY INFLATION | 4 | 67% | 0% | 4 | Search MEMORY+INFLATION | Search MEMORY+INFLATION |
5 | M157 | 3 | 100% | 0% | 3 | Search M157 | Search M157 |
6 | TSM5 | 3 | 100% | 0% | 3 | Search TSM5 | Search TSM5 |
7 | MOUSE CYTOMEGALOVIRUS | 3 | 45% | 1% | 5 | Search MOUSE+CYTOMEGALOVIRUS | Search MOUSE+CYTOMEGALOVIRUS |
8 | ANTIVIRAL CONTROL | 2 | 67% | 0% | 2 | Search ANTIVIRAL+CONTROL | Search ANTIVIRAL+CONTROL |
9 | CTL LINE | 2 | 67% | 0% | 2 | Search CTL+LINE | Search CTL+LINE |
10 | INTERFERON SIGNAL TRANSDUCTION | 2 | 67% | 0% | 2 | Search INTERFERON+SIGNAL+TRANSDUCTION | Search INTERFERON+SIGNAL+TRANSDUCTION |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | MOUSE CYTOMEGALOVIRUS | 45 | 48% | 8% | 69 |
2 | MURINE CYTOMEGALOVIRUS | 34 | 21% | 18% | 149 |
3 | LONG TERM DEPLETION | 30 | 55% | 5% | 37 |
4 | ACTIVATION RECEPTOR | 21 | 44% | 4% | 36 |
5 | TRANSCRIPTIONAL REACTIVATION | 17 | 62% | 2% | 18 |
6 | MURINE CYTOMEGALOVIRUS INFECTION | 16 | 22% | 8% | 64 |
7 | CLASS I COMPLEXES | 13 | 44% | 3% | 22 |
8 | CYTOLYTIC LYMPHOCYTE T | 9 | 36% | 2% | 20 |
9 | IMMUNE EVASION PROTEINS | 9 | 67% | 1% | 8 |
10 | HERPESVIRUS GENOME | 9 | 37% | 2% | 19 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Mast cells: innate attractors recruiting protective CD8 T cells to sites of cytomegalovirus infection | 2015 | 1 | 41 | 44% |
MHC class I immune evasion in MCMV infection | 2008 | 36 | 74 | 89% |
The interplay between host and viral factors in shaping the outcome of cytomegalovirus infection | 2007 | 55 | 116 | 53% |
Deciphering the role of DC subsets in MCMV infection to better understand immune protection against viral infections | 2014 | 3 | 138 | 53% |
Innate immunity regulates adaptive immune response: lessons learned from studying the interplay between NK and CD8(+) T cells during MCMV infection | 2012 | 9 | 61 | 61% |
Rapid and sequential quantitation of salivary gland-associated mouse cytomegalovirus in oral lavage | 2014 | 1 | 18 | 89% |
The evolutionary arms race between NK cells and viruses: Who gets the short end of the stick? | 2013 | 12 | 97 | 31% |
Viral latency drives 'memory inflation': a unifying hypothesis linking two hallmarks of cytomegalovirus infection | 2012 | 12 | 72 | 44% |
Pathogenesis of murine cytomegalovirus infection | 2003 | 104 | 102 | 64% |
All is fair in virus-host interactions: NK cells and cytomegalovirus | 2011 | 25 | 69 | 42% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | IMMUNOL VIROL PROGRAM | 2 | 18% | 1.5% | 12 |
2 | MED S 1030 | 2 | 67% | 0.2% | 2 |
3 | UK VIROL | 2 | 67% | 0.2% | 2 |
4 | LEHRSTUHL VIROL | 1 | 21% | 0.7% | 6 |
5 | MCGILL HOST ISTANCE | 1 | 100% | 0.2% | 2 |
6 | TUMOR VACCINAT | 1 | 100% | 0.2% | 2 |
7 | UNIV UM2 | 1 | 40% | 0.2% | 2 |
8 | IMMUNOTHER Y FZI | 1 | 33% | 0.2% | 2 |
9 | VIRUS CELL INTERACT GRP | 1 | 23% | 0.4% | 3 |
10 | BIOMED BIOCHEM CHEM SCI | 1 | 50% | 0.1% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000270284 | HUMAN CYTOMEGALOVIRUS//HCMV//US28 |
2 | 0.0000185022 | CMV SPECIFIC T CELLS//ONCOHEMATOL GRP//CYTOMEGALOVIRUS SPECIFIC T CELLS |
3 | 0.0000138755 | ECCELLENZA RIC BIOMED//NKG2C//NK CELL MATURATION |
4 | 0.0000099881 | KIR//LY49//KILLER CELL IMMUNOGLOBULIN LIKE RECEPTORS |
5 | 0.0000076185 | MHV 68//MURINE GAMMAHERPESVIRUS//MURINE GAMMAHERPESVIRUS 68 |
6 | 0.0000073277 | CMV DNA LOAD//HERPES HEPATITIS//HERPES SIMPLEX VIRUS PNEUMONIA |
7 | 0.0000069221 | HLA A2 GENE//NONCLASSICAL MHC I//DRUG DESIGN DEV GRP |
8 | 0.0000068898 | CYTOMEGALOVIRUS//VALGANCICLOVIR//GANCICLOVIR |
9 | 0.0000066647 | CONGENITAL INFECTION//CONGENITAL CYTOMEGALOVIRUS INFECTION//CYTOMEGALOVIRUS |
10 | 0.0000066470 | LYMPHOCYTIC CHORIOMENINGITIS VIRUS//VIRUS INDUCED MENINGITIS//CNRSESA 7087 |